Stockholders’ Equity - Stock Incentive Plan for the Indicated Periods (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Weighted-Average Exercise Price
Outstanding at end of period (in dollars per share)	$ 12.78
Weighted-Average Remaining Contractual Term (in years)	3 years 9 months 18 days
Equity Option
Number of Shares
Outstanding at beginning of period (in shares)	67,500	90,000
Options canceled and retired (in shares)		(22,039)
Options exercised (in shares)	(18,750)	(461)
Outstanding at end of period (in shares)	48,750	67,500	90,000
Options vested and exercisable and expected to be vested and exercisable at December 31, 2024 (in shares)	48,750
Options vested and exercisable and expected to be vested and exercisable at December 31, 2024 (in shares)	48,750
Weighted-Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 12.70	$ 10.88
Options canceled and retired (in dollars per share)		16.29
Options exercised (in dollars per share)	12.50	16.29
Outstanding at end of period (in dollars per share)	12.78	$ 12.70	$ 10.88
Options vested and exercisable and expected to be vested and exercisable at December 31, 2024 (in dollars per share)	12.78
Options vested and exercisable at December 31, 2024 (in dollars per share)	$ 12.78
Weighted-Average Remaining Contractual Term (in years)	3 years 9 months 18 days	5 years	6 years 3 months 18 days
Options vested and exercisable and expected to be vested and exercisable Weighted-average remaining contractual term	3 years 9 months 18 days
Options vested and exercisable weighted-average remaining contractual term	3 years 9 months 18 days
Aggregate Intrinsic Value (in thousands)	$ 137	$ 326	$ 364
Options vested and exercisable and expected to be vested and exercisable aggregate intrinsic value	137
Options vested and exercisable aggregate intrinsic value	$ 137